A Study to Measure Relationship Between Antimüllerian Hormone and Initial Dose of Menopur®
Status:
Completed
Trial end date:
2018-06-19
Target enrollment:
Participant gender:
Summary
AME is a non-interventional, prospective, longitudinal and multicenter study. This study aims
to measure the relationship between antimüllerian hormone serum level (AMH), as measured by a
fully automated assay and the initial dose of Menopur® HP-hMG 600 IU/mL prescribed for
infertile women undergoing their first IVF/ICSI cycle in the current practice.